City Therapeutics Raises $99.5M in Series B Funding

June 9, 2026

City Therapeutics, Inc., a Cambridge, MA-based biopharmaceutical company developing RNA interference (RNAi)-based medicines, raised $99.5M in Series B funding

Search

RECENT PRESS RELEASES

Innovations driving the future of technology in gambling

SWI Editorial Staff2026-06-09T02:17:54-07:00June 9, 2026|

SpaceX IPO: This Will Be the No. 1 Takeaway for Investors in 2026

SWI Editorial Staff2026-06-09T01:42:00-07:00June 9, 2026|

European defense stocks slide after Morgan Stanley downgrades sector view

SWI Editorial Staff2026-06-09T01:38:03-07:00June 9, 2026|

The impact of sports on building community ties in World Cup 2026 Prediction Today

SWI Editorial Staff2026-06-09T01:47:01-07:00June 9, 2026|

City Therapeutics Raises $99.5M in Series B Funding

SWI Editorial Staff2026-06-09T01:31:17-07:00June 9, 2026|

Federal, State Tax Laws Boost Data Centers’ Return-on-Investment

SWI Editorial Staff2026-06-09T01:30:05-07:00June 9, 2026|